Intercept Pharma (ICPT) Gains as Novartis (NVS) Said Interested in Bid

December 28, 2016 11:22 AM EST

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Intercept Pharma (NASDAQ: ICPT) is gaining 5% mid-day on word Novartis (NYSE: NVS) is interested in a takeover of the company in a deal that could be announced in the mid-January, according to a source. In the past, Gilead Sciences (NASDAQ: GILD) was also said to be interested.

"It is our company policy not to comment on M&A speculation," an Intercept spokesperson told StreetInsider.com.

(updated with company statement)



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Hot M&A, Mergers and Acquisitions, Rumors